黑料吃瓜群网

Research to identify patients who will benefit most from a life-saving machine that acts as the heart and lungs following organ failure has received a $1 million federal government funding boost.

The Minister for Health and Aged Care, The Hon Mark Butler, announced the $999,779.40 (MRFF) Cardiovascular Health Mission grant during a visit to The Alfred鈥檚 Intensive Care Unit on National Heart Day.

The research involves the high-tech Extracorporeal Membrane Oxygenation (ECMO) machine, which simulates a heart/lung bypass after acute cardiac and respiratory failure and cardiac arrest. It can replace a non-functioning heart or lungs for weeks.

ECMO is used in adults, children and newborns when all other forms of life support have failed. It has increased survival in these patients to around 60%. In the past five years, its use has doubled in Australia and globally.

The newly funded PRecision Ecmo in CardIogenic Shock Evaluation: PRECISE Study is led by Monash University鈥檚 Dr Aidan Burrell, in collaboration with Alfred Health, St Vincent鈥檚 黑料吃瓜群网 Sydney, The University of Sydney and The University of Queensland鈥檚 Critical Care Research Group.

PRECISE will recruit 236 patients to investigate whether biomarkers can better identify patients who will derive the best long-term benefit from ECMO. The study is embedded in the National ECMO Registry () led by Professor Carol Hodgson, head of the Division of Clinical Trials and Cohort Studies, School of Public Health and Preventive Medicine, Monash University.

The EXCEL registry covers over 95% of ECMO patients nationally and includes over 1000 receiving ECMO. Over three years, the registry has embedded at least six clinical trials, including three randomised controlled trials to test early interventions aimed at improving patient outcomes.

Hodgson said the PRECISE study aimed to improve patient outcomes by 鈥渂ridging the gap between bench and bedside鈥�.

鈥淲e have the unique opportunity to use this funding for the PRECISE study within a national ECMO registry to find the link between early biomarkers and long-term recovery in patients who have severe heart failure and need ECMO to survive,鈥� Hodgson said.

鈥淭his will help patients and families understand the recovery trajectory after critical illness and will help clinicians plan for the needs of their patients.鈥�

Image credit: Supplied.